Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Pharmacogenetics-based new therapeutic concepts.

Ivar Roots1, Thomas Gerloff, Christian Meisel

  • 1Institut für Klinische Pharmakologie, Charité-Universitätsmedizin Berlin, Campus Charitè Mitte, Humboldt-Universität zu Berlin, Berlin, Germany. ivar.roots@charite.de

Drug Metabolism Reviews
|November 24, 2004
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Between Patterns and Predictions: Interpretable Latent EEG Representations for Clinical Insights.

medRxiv : the preprint server for health sciences·2026
Same author

Infarct-associated oligoclonal T cell expansion in chronic experimental stroke across age, sex, and models.

Experimental neurology·2026
Same author

Adiponectin modulates the diurnal hepatic transcriptome and energy metabolism in male mice.

Endocrine connections·2026
Same author

The 8th European Society of Pharmacogenomics and Personalized Therapy (ESPT) congress.

Pharmacogenomics·2026
Same author

Functional Outcome Following Blood Pressure Drops Within 24 Hours After Successful Mechanical Thrombectomy.

Neurology·2026
Same author

Pharmacogenetics-Not Just Low-Hanging Fruit.

Clinical pharmacology and therapeutics·2026
Same journal

Humanized mouse models for drug metabolism and drug transport: a systematic review.

Drug metabolism reviews·2026
Same journal

Drug transporters in drug disposition - highlights from the year 2025.

Drug metabolism reviews·2026
Same journal

Herbal supplements and anti-tuberculosis therapy: unlocking hidden interactions for better multidrug-resistant tuberculosis management.

Drug metabolism reviews·2026
Same journal

Identification and characterization of a novel aldehyde metabolite of WIN18,446 and associated WIN18,446-ALDH1A2 protein adducts using mass spectrometry.

Drug metabolism reviews·2026
Same journal

Pharmacomicrobiomics in precision pharmacotherapy: bidirectional microbial-drug interactions as a key determinant of therapeutic response.

Drug metabolism reviews·2026
Same journal

Population pharmacokinetics of levofloxacin: a systematic review.

Drug metabolism reviews·2026
See all related articles

Pharmacogenetics tailors drug therapy by analyzing genetic factors influencing drug response and metabolism. Genetic testing helps personalize medication and dosage, improving treatment efficacy and reducing adverse effects.

Area of Science:

  • Clinical Pharmacology
  • Genetics

Background:

  • Pharmacogenetics investigates genetic influences on drug response.
  • Understanding hereditary traits enables personalized drug selection and dosage.
  • This field enhances therapeutic precision in clinical practice.

Purpose of the Study:

  • To elucidate the role of genetic variations in drug metabolism and transport.
  • To highlight the impact of genetic factors on drug efficacy and safety.
  • To explore the utility of genetic testing in clinical treatment decisions.

Main Methods:

  • Examining genetic variations in drug metabolizing enzymes (e.g., cytochrome P450 2D6, CYP2C19).
  • Investigating genetic influences on drug transporters (e.g., p-glycoprotein).
  • Reviewing the correlation between genetic profiles and patient responses to specific drugs.

Related Experiment Videos

Main Results:

  • Genetic variations in enzymes like CYP2C19 affect drug dosage requirements and response.
  • Deficient enzyme activity can lead to increased adverse drug effects.
  • Certain genetic variants, like CYP2C19 deficiency, can enhance the efficacy of drugs such as proton pump inhibitors.

Conclusions:

  • Pharmacogenetics provides a scientific basis for tailoring drug therapy based on individual genetic makeup.
  • Genetic testing can identify patients likely to respond or not respond to specific treatments.
  • The integration of pharmacogenetics into clinical practice optimizes therapeutic outcomes and patient safety.